What caused BBM.CN stock to drop 33% today?

The drop reflects thin liquidity and small order imbalance. Volume rose to **5,000** vs avg **3,120**, so modest selling pushed the price from **C$0.015** to **C$0.01**. No major corporate news explained the move.

What is Meyka AI’s view on BBM.CN stock?

Meyka AI rates BBM.CN **63.64/100 (Grade B, HOLD)**. The grade weighs benchmark and sector comparison, growth, metrics, and forecasts. This is informational, not investment advice.

What is the short-term forecast for BBM.CN stock?

Meyka AI’s model projects a 12-month price of **C$0.00198**, implying about **-80.17%** from the current **C$0.01**. Forecasts are model-based projections and not guarantees.

Which risks should investors watch for BBM.CN stock?

Key risks are low liquidity, negative margins, dilution from financing, and operational exposure in Colombia. Days sales outstanding of **200** and low cash per share raise execution risk.

CA Stocks

BBM.CN drops 33% Jan 13 2026 on CNQ: Blueberries Medical faces liquidity risk

ByHuzaifa Zahoor January 13, 2026January 13, 2026

BBM.CN stock opened market hours on Jan 13 2026 at C$0.01 and fell 33.33%, marking it among today’s top losers on the CNQ (Canada). Volume reached 5,000 shares, above the 3,120 average. The slide follows thin liquidity and limited market depth in Blueberries Medical Corp. (BBM.CN), which trades in small lots and shows a negative EPS of -0.01. We examine valuation, trading metrics, risks, and forecast to explain the drop and what investors should watch next.